Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does POMALIDOMIDE Cause Intentional product use issue? 393 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 393 reports of Intentional product use issue have been filed in association with POMALIDOMIDE (Pomalyst). This represents 0.4% of all adverse event reports for POMALIDOMIDE.

393
Reports of Intentional product use issue with POMALIDOMIDE
0.4%
of all POMALIDOMIDE reports
28
Deaths
32
Hospitalizations

How Dangerous Is Intentional product use issue From POMALIDOMIDE?

Of the 393 reports, 28 (7.1%) resulted in death, 32 (8.1%) required hospitalization, and 4 (1.0%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for POMALIDOMIDE. However, 393 reports have been filed with the FAERS database.

What Other Side Effects Does POMALIDOMIDE Cause?

Plasma cell myeloma (7,023) Death (6,795) Fatigue (6,530) Pneumonia (5,792) Off label use (3,845) Diarrhoea (3,351) White blood cell count decreased (3,328) Neutropenia (3,029) Rash (2,715) Dyspnoea (2,543)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which POMALIDOMIDE Alternatives Have Lower Intentional product use issue Risk?

POMALIDOMIDE vs POMALYST POMALIDOMIDE vs PONATINIB POMALIDOMIDE vs PONATINIB\PONATINIB POMALIDOMIDE vs PONESIMOD POMALIDOMIDE vs PORACTANT ALFA

Related Pages

POMALIDOMIDE Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue POMALIDOMIDE Demographics